Earnings
Humacyte Puts Production Ahead Of Pancreas Expansion As Symvess Sales Accelerate
October Symvess revenue reached $0.8 million, while management expects fourth-quarter sales to at least double the third quarter.
Humacyte (HUMA) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
October Symvess revenue reached $0.8 million, while management expects fourth-quarter sales to at least double the third quarter.
Earnings
Symvess reached 49 hospital customers, and Humacyte expects fourth-quarter sales to at least double the third quarter’s.